A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research.

Rihn, Suzannah JORCID logo; Merits, Andres; Bakshi, Siddharth; Turnbull, Matthew LORCID logo; Wickenhagen, ArthurORCID logo; Alexander, Akira JTORCID logo; Baillie, Carla; Brennan, BenjaminORCID logo; Brown, Fiona; Brunker, Kirstyn; +72 more...Bryden, Steven RORCID logo; Burness, Kerry A; Carmichael, Stephen; Cole, Sarah J; Cowton, Vanessa M; Davies, PaulORCID logo; Davis, Chris; De Lorenzo, GiudittaORCID logo; Donald, Claire LORCID logo; Dorward, Mark; Dunlop, James I; Elliott, Matthew; Fares, Mazigh; da Silva Filipe, AnaORCID logo; Freitas, Joseph R; Furnon, WilhelmORCID logo; Gestuveo, Rommel JORCID logo; Geyer, Anna; Giesel, Daniel; Goldfarb, Daniel MORCID logo; Goodman, NicolaORCID logo; Gunson, Rory; Hastie, C JamesORCID logo; Herder, VanessaORCID logo; Hughes, JosephORCID logo; Johnson, Clare; Johnson, NatashaORCID logo; Kohl, Alain; Kerr, Karen; Leech, HannahORCID logo; Lello, Laura Sandra; Li, Kathy; Lieber, GauthierORCID logo; Liu, Xiang; Lingala, Rajendra; Loney, Colin; Mair, DanielORCID logo; McElwee, Marion J; McFarlane, Steven; Nichols, JennaORCID logo; Nomikou, KyriakiORCID logo; Orr, Anne; Orton, Richard JORCID logo; Palmarini, Massimo; Parr, Yasmin AORCID logo; Pinto, Rute MariaORCID logo; Raggett, Samantha; Reid, Elaine; Robertson, David LORCID logo; Royle, JamieORCID logo; Cameron-Ruiz, NataliaORCID logo; Shepherd, James GORCID logo; Smollett, KatherineORCID logo; Stewart, Douglas G; Stewart, MeredithORCID logo; Sugrue, ElenaORCID logo; Szemiel, Agnieszka M; Taggart, AislynnORCID logo; Thomson, Emma CORCID logo; Tong, LilyORCID logo; Torrie, Leah S; Toth, Rachel; Varjak, Margus; Wang, Sainan; Wilkinson, Stuart GORCID logo; Wyatt, Paul G; Zusinaite, Eva; Alessi, Dario R; Patel, Arvind HORCID logo; Zaid, AliORCID logo; Wilson, Sam JORCID logo; and Mahalingam, SureshORCID logo (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS biology, 19 (2). e3001091-. ISSN 1544-9173 DOI: 10.1371/journal.pbio.3001091
Copy

The recent emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the underlying cause of Coronavirus Disease 2019 (COVID-19), has led to a worldwide pandemic causing substantial morbidity, mortality, and economic devastation. In response, many laboratories have redirected attention to SARS-CoV-2, meaning there is an urgent need for tools that can be used in laboratories unaccustomed to working with coronaviruses. Here we report a range of tools for SARS-CoV-2 research. First, we describe a facile single plasmid SARS-CoV-2 reverse genetics system that is simple to genetically manipulate and can be used to rescue infectious virus through transient transfection (without in vitro transcription or additional expression plasmids). The rescue system is accompanied by our panel of SARS-CoV-2 antibodies (against nearly every viral protein), SARS-CoV-2 clinical isolates, and SARS-CoV-2 permissive cell lines, which are all openly available to the scientific community. Using these tools, we demonstrate here that the controversial ORF10 protein is expressed in infected cells. Furthermore, we show that the promising repurposed antiviral activity of apilimod is dependent on TMPRSS2 expression. Altogether, our SARS-CoV-2 toolkit, which can be directly accessed via our website at https://mrcppu-covid.bio/, constitutes a resource with considerable potential to advance COVID-19 vaccine design, drug testing, and discovery science.


picture_as_pdf
journal.pbio.3001091.pdf
subject
Published Version
Available under Creative Commons: Attribution 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads